Scientific Career Development Grant
The Scientific Career Development Grant is a unique opportunity for scientific renewal, new research development and the establishment of collaborative links for both physicians and scientists.
- Up to €11,000 is available for recipients to spend a period of 3 to 12 months in another centre.
- Applicants should be an ESPE member
- The applicant should be 40 years of age or above and not less than 3 years from retirement
- Current members of the Science Committee and ESPE Council are not eligible to apply for this grant
- A grant must be activated within 6 months of receipt
The applications will be scored based on the following criteria:
- Applicant CV
- Host CV and institution
- Focus and quality of application
- Methodology and experimental design
- Potential for publication and further research
- Timing and feasibility
- Budget justification
- Benefit for applicant and home institution
- Relevance of the topic
All applications will be subjected to an external peer review by at least three members of the Science Committee Expert Panel using the reviewer evaluation form.
How to Apply
The following documents should be submitted by the application deadline.
- Application form
- Short CV of applicant
- List of publications
- Invitation from host institution
- Short CV of the host(s)
- Declaration letter from home institute
- Ethical committee approval – if applicable
Applications must be submitted electronically to Outi Mäkitie, ESPE Scientific Career Development Grant Convener.
Post Award Information
The forms below are for recipients of this grant only. A grant report should be submitted within 3 months of completion of the grant.
Completed forms must be submitted electronically to the ESPE Team.
2017 Professor Fabrizio Barbetti, Rome, Italy. PSC to beta cell for the study of disease of neonatal diabetes and as potential therapeutic tool. Host: Professor Dieter Egli, Naomi Berrie Diabetes Center - Columbia University, New York, USA.
2017 Professor Maria Veronica Mericq, Chile. Kinetics of Early Growth: Determinants and Links with Subsequent Health in the Birth Cohorts: Eden and Elfe. Host: Professor Michel Polak, Necker University Hospital, Paris, France.
2016 Professor Ragnar Bjarnason, Reykjavik, Iceland. The Mechanism of Human Non–shivering Thermogenesis and Basal Metabolic Rate. Host: Dr Kong Y. Chen, Bethesda, USA.
2015 Professor Annette Gruters–Kieslich, Berlin, Germany. Towards precision medicine in rare undiagnosed endocrine phenotypes. Host: Professor Harald Jueppner, Boston, USA and Professor Eric Vilain, Los Angeles, USA.
2015 Dr Leyla Akin, Kayseri, Turkey: Evaluation of the molecular basis of an unusual phenotype characterized by GH deficiency and primary ovarian failure occurring in multiple Turkish pedigrees. Host: Professor Mehul Dattani, UCL Institute of Child Health/Great Ormond Street Hospital for Children, London, UK.
2014 Professor Jean-Pierre Chanoine, Vancounver, Canada: Bringing Global Pediatric Endocrinology and Diabetes (GPED) to the front stage: Establishing its future as a key player in the field of non-communicable diseases. Host: Dr. Karen Armstrong, Sydney, Australia and Dr. Margaret Zacharin, Melbourne, Australia.
2014 Dr Giedre Grigelioniene, Stockholm, Sweden: Searching for genetic causes of pseudohypoparathyroidism type Ib. Host: Professor Harald Juppner, Endocrine Unit, Department of Medicine, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA.
2013 Professor Gary Butler, London, UK: The aetiology and clinical management of children and adolescents with hypogonadotropic hypogonadism: a network collaboration Host: Professor Leo Dunkel, Centre for Endocrinology, St Bartholomew's and The London School of Medicine, London, UK.
2013 Dr Anne–Simone Parent, Liège, Belgium: Effects of perinatal exposure to endocrine disrupting chemicals on hippocampal neuro Host: Professor Westbrook, Vollum Institute, Oregon Health and Science University, Portland, OR, USA.
2012 Outi Makitie, Helsinki, Finland: Genetic determinants of childhood onset primary osteoporosis Host: Professor Olle Söder, Department of Women's and Children's Health, Pediatric Endocrinology Unit, Karolinska University Hospital, Stockholm, Sweden.
2010 Serap Turan, Istanbul, Turkey: The temporal profile of Gs imprinting and XLs expression in the renal proximal tubule during the early postnatal period in mice (see report. Host: Henry Kronenberg and Murat Bastepe, Boston, Massachusetts, USA.
2009 Fabrizio Barbetti, Rome, Italy: RNA–based therapy for infancy onset diabetes caused by mutations of the insulin gene. Host: Domenico Accili.
2008 Theo Sas, Ridderkerk, The Netherlands: The role of Plasma Protein–A (PAPP–A) in pre– and postnatal growth. A study in normal and fetal growth restricted pregnancies and in children born small for gestational age (SGA) with or without Silver Russell Syndrome (SRS). Host: Yves Le Bouc, France.
2007 Primus Mullis, Bern, Switzerland: Rescuing autosomal dominant growth hormone deficiency type II. Host: Iain Robinson, UK
2007: Jacques Pantel, Paris, France: The ghrelin system in the zebra fish model. Host: R D Cone, USA.
2004 Pal Njolstad, Bergen, Norway. Host: Ronald Kahn, USA.
2003 Serge Lumbroso Nimes, France.
2003 Christian Roth Bonn, Germany.
2002 Jeremy Wales, Sheffield, UK.
2001 Jeremy Wales Sheffield, UK.
2001 Niels Birkebaek Aarhus, Denmark.
2001 Heike Jung Hanover, Germany.
2001 Nurgun Kandemir Ankara, Turkey.
2000 Ursula Kuhnle–Krahl, Munich, Germany.
1999 Marie–Christine Lebrethon, Liège, Belgium.
1998 Cecilia Camacho–Hübner, London, UK.
1997 – Not awarded.
1996 Alex Eberle Basel, Switzerland; Marc Maes Brussels, Belgium.
1996 Raimo Voutilainen Kuopio, Finland.
1995 – Not awarded.
1994 Michael Preece London, UK.
1993 David Milner (d. 1996) Sheffield, UK.
1993 Tomasz Romer Warsaw, Poland.